117 related articles for article (PubMed ID: 26461141)
1. MicroRNA‑361‑5p suppresses cancer progression by targeting signal transducer and activator of transcription 6 in non‑small cell lung cancer.
Ma Y; Bao C; Kong R; Xing X; Zhang Y; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Zhang D; Ma Z; Sun L; Zhou B
Mol Med Rep; 2015 Nov; 12(5):7367-73. PubMed ID: 26461141
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR‑361‑5p plays an oncogenic role in human lung adenocarcinoma through the regulation of SMAD2.
Othman N; Nagoor NH
Int J Oncol; 2019 Jan; 54(1):306-314. PubMed ID: 30365047
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
4. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
Wang X; Chen Z
Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
[TBL] [Abstract][Full Text] [Related]
6. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
[TBL] [Abstract][Full Text] [Related]
7. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
8. MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.
Chen X; Chen S; Hang W; Huang H; Ma H
Biomed Pharmacother; 2014 Jun; 68(5):589-95. PubMed ID: 24835695
[TBL] [Abstract][Full Text] [Related]
9. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
Huang J; Sun C; Wang S; He Q; Li D
Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatment.
Li Q; Yang Z; Chen M; Liu Y
Int J Mol Med; 2016 Apr; 37(4):1067-74. PubMed ID: 26936095
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.
Ke Y; Zhao W; Xiong J; Cao R
FEBS Lett; 2013 Sep; 587(18):3153-7. PubMed ID: 23954293
[TBL] [Abstract][Full Text] [Related]
12. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2015; 8(4):3827-34. PubMed ID: 26097565
[TBL] [Abstract][Full Text] [Related]
13. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression.
Wang M; Zhang Q; Wang J; Zhai Y
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C107-11. PubMed ID: 26323905
[TBL] [Abstract][Full Text] [Related]
15. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
16. FOXD3 suppresses tumor growth and angiogenesis in non-small cell lung cancer.
Yan JH; Zhao CL; Ding LB; Zhou X
Biochem Biophys Res Commun; 2015 Oct; 466(1):111-6. PubMed ID: 26341266
[TBL] [Abstract][Full Text] [Related]
17. miR-25 targets the modulator of apoptosis 1 gene in lung cancer.
Wu T; Chen W; Kong D; Li X; Lu H; Liu S; Wang J; Du L; Kong Q; Huang X; Lu Z
Carcinogenesis; 2015 Aug; 36(8):925-35. PubMed ID: 25998847
[TBL] [Abstract][Full Text] [Related]
18. MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.
Shi H; Ji Y; Zhang D; Liu Y; Fang P
Biochem Biophys Res Commun; 2015 Sep; 465(1):125-30. PubMed ID: 26235874
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
[TBL] [Abstract][Full Text] [Related]
20. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]